Computation of FFR CT from Cardiac CT: Does it improve diagnostic accuracy?

Similar documents
Non-invasive FFR Using Coronary CT Angiography and Computational Fluid Dynamics Predicts the Hemodynamic Significance of Coronary Lesions

FFR CT : Clinical studies

For the NXT Investigators

Non-invasive functional testing in 2014

MYOCARDIAL PERFUSION COMPUTED TOMOGRAPHY PhD course in Medical Imaging. Anne Günther Department of Radiology OUS Rikshospitalet

Efficient Evaluation of Chest Pain

Main Effect of Screening for Coronary Artery Disease Using CT

Listen to your heart: Good Cardiovascular Health for Life

Section 8: Clinical Exercise Testing. a maximal GXT?

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Mattias Törnerud, Capio St Görans sjukhus AB, Stockholm. Invasiv tryckmätning FFR

Renovascular Hypertension

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

Diagnostic and Therapeutic Procedures

Cilostazol versus Clopidogrel after Coronary Stenting

Press. Siemens solutions support diagnosis and treatment of cardiovascular diseases

Majestic Trial 12 Month Results

Merge Healthcare Cardiology Differentiators. A Merge White Paper

Corporate Medical Policy

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

CARDIOLOGY PROCEDURES REQUIRING PRECERTIFICATION

Duration of Dual Antiplatelet Therapy After Coronary Stenting

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

Heart Center Packages

California Health and Safety Code, Section

Procedure Codes. RadConsult provides real-time decision support for physicians who order high-cost imaging procedures RADIATION THERAPY

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD

Noninvasive testing can provide useful information for

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

Perioperative Cardiac Evaluation

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

Purpose: To outline training and competency standards for non-physician staff who supervise cardiac stress tests at UK HealthCare.

Low-dose CT for Pulmonary Embolism

Clinical Study Synopsis

Stress Echocardiogram

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Express Introductory Training in ANSYS Fluent Lecture 1 Introduction to the CFD Methodology

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

Imaging of Thoracic Endovascular Stent-Grafts

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa Objectives. No disclosures, no conflicts

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to Reference Code: GDMECR0061PDB. Publication Date: May 2014

Modeling and Numerical Blood Flow Analysis of Tibial Artery using CFD

LEADERS: 5-Year Follow-up

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Prognostic impact of uric acid in patients with stable coronary artery disease

Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs

Drug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam

CV Disease : A Major Threat to Public Health

Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

PCI vs. CABG for Left Main Disease

Antiaggreganti. STEMI : cosa c è di nuovo? Heartline Genova Novembre 2015

THE ACADEMY OF MEDICINE OF MALAYSIA January 2005 CREDENTIALING REQUIREMENTS FOR THE SPECIALITY OF CARDIOLOGY

Utilizing the Cath Lab for Cardiac Arrest

Cardiovascular Practice Quality Improvement : Role of ACC-NCDR and HIT

The Role Of Early Stress Testing In Assessing Low Risk Chest Pain Patients Admitted Through The Emergency Department

CARDIAC RISKS OF NON CARDIAC SURGERY

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Objectives. Cardiac Substrate Metabolism SNM Mid-Winter Educational Symposium

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine

Platelet Function Testing vs Genotyping : Focus on Pharmacogenomics of Clopidogrel. Kiyuk Chang, M.D., Ph.D.

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Subclavian Steal Syndrome By Marta Thorup

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

on behalf of the AUGMENT-HF Investigators

INTRODUCTION TO EECP THERAPY

38 year old female with mild obesity. She is planning an exercise program to loose weight. She has no other known risk factors for CAD.

CHAPTER 4 QUALITY ASSURANCE AND TEST VALIDATION

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?

GE Healthcare CASE. Cardiac Assessment System for Exercise Testing. Connecting hearts and minds.

Translating Science to Health Care: the Use of Predictive Models in Decision Making

Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity

Intracoronary Stenting and. Robert A. Byrne, Julinda Mehilli, Salvatore Cassese, Franz-Josef Neumann, Susanne Pinieck, Tomohisa Tada,

CPT * Codes Included in AIM Preauthorization Program for 2013 With Grouper Numbers

Adaptation of General Purpose CFD Code for Fusion MHD Applications*

CARDIOLOGY Delineation of Privileges

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

Now bring the advantages of digital workflow to cardiology

Chronic Thromboembolic Disease. Chronic Thromboembolic Disease Definition. Diagnosis Prevention Treatment Surgical Nonsurgical

Using Clinical Registries to Create Evidence-based Health Care Policy : Experiences from Ontario, Canada

ECG may be indicated for patients with cardiovascular risk factors

Customer Training Material. Lecture 2. Introduction to. Methodology ANSYS FLUENT. ANSYS, Inc. Proprietary 2010 ANSYS, Inc. All rights reserved.

Septic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident

doi: /j.jacc This information is current as of October 16, 2008

Model of a flow in intersecting microchannels. Denis Semyonov

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

SUPERCHARGED. CUSTOM-DESIGNED FOR CARDIOLOGY. Cardiology PACS. Cardiology

Getting smart about dyspnea and life saving drug therapy in ACS patients. Kobi George Kaplan Medical Center Rehovot

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code )

Cancer Treatment and the Heart Cardio-Oncology September 12, 2014

Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up

11. Analysis of Case-control Studies Logistic Regression

Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI

Transcription:

Computation of FFR CT from Cardiac CT: Does it improve diagnostic accuracy? Jonathon Leipsic MD FRCPC FSCCT Assistant Professor of Radiology and Cardiology Vice Chairman of Research Dept Radiology UBC President Canadian Chapter Society of Cardiovascular CT Disclosures: Research support (NHLBI; QNRF; GE Healthcare; Philips Medical, Vital Images); Medical Advisory Board (GE Healthcare); Equity Interest (TC3 Cardiovascular Core Laboratories; Cedars-Sinai Medical Center)

Coronary CT Angiography for Diagnosis of Obstructive CAD Test Sensitivity Specificity Exercise ECG treadmill 1 68% 77% Exercise Echo treadmill 2 86% 81% Dobutamine Echo 2 ~85% ~85% Exercise nuclear treadmill 3 87% 73% Pharmacologic nuclear 3 89% 75% Coronary CTA 4 95% 83% 1. ACC/AHA 2002 Guideline Update for Exercise Testing 2. ACC/AHA/ASE 2003 Guideline Update for the Application of Echocardiography 3. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging 4. ACCURACY study

Decisions of Revascularization Based Upon Angiography Alone COURAGE Trial (D/MI/CVA) BARI 2D Trial (D/MI/CVA) 2,287 individuals with angiographically obstructive CAD and ischemia assigned to PCI or medical tx and followed for 4.6 years 2,368 diabetic patients assigned to revascularization or medical tx and followed for 5 years Source: Boden et al. NEJM 2007; BARI 2D Study Group, NEJM 2009

log Hazard Ratio Ischemia-Guided Revascularization Therapeutic Benefit Based Upon MPS Findings Myocardial Perfusion Imaging Revascularization vs Medical Rx 0 1 2 3 4 5 6 10,627 patients No CAD 1.9 yr cardiac death Medical Rx Revasc *p<0.001 0 12.5% 25% 32.5% 50% Source: Hachamovitch, et al Circulation 2003 % Myocardium Ischemic

Assessment of Lesion-specific Ischemia by FFR is the Only Method To Improve Event-free Survival Source: Tonino et al. NEJM 2009;360:213-24; Pijls et al. J Am Coll Cardiol 2010

Can CCTA diagnose ischemia? CCTA has a high sensitivity and high NPV for diagnosis of obstructive CAD However, CCTA does not define the hemodynamic significance of coronary lesions Only one of these patients has hemodynamically significant CAD. Which one is it? >50% diameter stenosis >50% diameter stenosis

Reference Gold Standard for Ischemia: Fractional Flow Reserve (FFR) FFR at the time of invasive coronary angiography (ICA) is the only method for specific determination of the hemodynamic significance of coronary artery lesions (lesion-specific ischemia) FFR = Ratio of maximal myocardial blood flow through a diseased artery to the blood flow in the hypothetical case that this artery is normal Values <0.80 or <0.75 considered diagnostic of lesion-specific ischemia Source: Pijls NH et al. J Am Coll Cardiol. 2007; Pijls NH et al. J. Am. Coll. Cardiol. 2010

CCTA Stenosis Demonstrates an Unreliable Relationship to Lesion-Specific Ischemia CCTA correlates favorably with angiographic estimate of coronary stenosis but unreliably estimates hemodynamic significance of lesions as determined by FFR FFR 0.89 Source: Meijboom et al. J Am Coll Cardiol 2008 75% false positives

Computational Fluid Dynamics Computational fluid dynamics (CFD) quantifies fluid pressure and velocity, based on physical laws of mass conservation and momentum balance CFD for Patient-Specific Models of Coronary Arteries 1. Numerical method approximates governing equations 2. Obtain solution for velocity / pressure at finite (but very large) number of points 3. Simultaneously solve millions of non-linear equations and repeating process for thousands of time intervals within cardiac cycle Images courtesy of Prof. Charbel Farhat, Dept. of Aeronautics & Astronautics, Stanford University

FFR can now be derived from CCTA Detailed maps of pressure and velocity can be obtained computationally Input Data Geometry - obtained from design specifications Fluid properties viscosity and density of air Equations of fluid flow solved on supercomputers Computed velocity, pressure, lift and drag Geometry represented as a mesh Equations of fluid flow solved for each point on this mesh P = P atm Atmosphe ric pressure Velocity of air relative to wing Boundary Conditions Velocity of incoming air relative to wing Atmospheric pressure Source: Courtesy of Charley Taylor, Stanford University

Simulating coronary blood flow uses similar principles but is even more complicated Patient-specific geometry Heart-Vessel Interactions Complex fluid Properties Inputs Accurate coronary geometric models including branching structure and pathology Physiologic models personalized using minimal measured data Boundary Conditions Heart/vascular interaction Aortic impedance Time-varying coronary resistance related to intramyocardial pressure Models to simulate hyperemia Flow demand related to myocardial mass, cardiac work, etc Microcirculatory resistance depends on complex vessel structure Physiology changes due to administration of drugs to induce hyperemia Numerical Methods Anisotropic, adaptive, boundary layer mesh generation to reduce computation time Tight coupling between heart model and aorta/coronary model High performance parallel incompressible flow solver

FFR CT is determined from typically-acquired CCTA 1. No additional image acquisition 2. No excess radiation 3. No modification to imaging protocols (prospective or retrospective gating) 4. No administration of adenosine or other medications 3D FFR CT map computed FFR CT = 0.72 (can select any point on model)

DISCOVER-FLOW: Diagnosis of ischemia-causing stenoses obtained via non-invasive fractional flow reserve Objective: To determine the diagnostic performance of non-invasive FFR CT, as compared to invasively measured FFR Study design Prospective multicenter study 1. Seoul National University Hospital, Seoul, Korea 2. Pauls Stradins University, Riga, Latvia 3. Inje University Paik Hospital, Koyang, Korea 4. Stanford University, Stanford, CA, USA 5. New York Presbyterian Hospital, NY, USA Sample size calculation Assumed diagnostic accuracy of CCTA stenosis for FFR-ischemia = 49% 2 150 vessels required to detect an improvement in diagnostic accuracy of FFR CT by 25% Type I error: 0.05, statistical power: 90% Source: Koo et al. J Am Coll Cardiol 2011; 2 Meijboom et al. J Am Coll Cardiol 2008

Diagnostic Performance of FFR CT and CCTA 25% Source: Koo et al. J Am Coll Cardiol 2011

Diagnostic Performance of FFR CT and CCTA ROC curve analysis Per-Vessel Per-Patient 1 1 FFR-CT FFR-CT Sensitivity CT alone Sensitivity CT alone Area Under the Curve Area Under the Curve FFR CT = 0.90 CCTA = 0.75 P=0.001 FFR CT = 0.92 CCTA = 0.70 P=0.0001 0 1 - Specificity 0 1 0 1 - Specificity 0 1 Source: Koo et al. J Am Coll Cardiol 2011

Examples DISCOVER-FLOW CCTA FFR CT Invasive angiography FFR FFR 0.74 >50% diameter stenosis FFR CT 0.74 ischemia >50% diameter stenosis FFR 0.74 ischemia FFR 0.85 >50% diameter stenosis FFR CT 0.85 no ischemia >50% diameter stenosis FFR 0.84 no ischemia

What about intermediate stenoses? 50-70% 50-70% Source: Tonino PA et al. J Am Coll Cardiol

Moderate vs. Severe Stenosis: Moving Beyond a Binary Approach Stenosis Severity 0-24% 25-49% 50-69% >70% 100% Cheng et al. JACC CV Imaging (Jul 2008)

Diagnostic Performance of FFRCT for 30-69% Stenoses by CCTA FFR CT Accuracy Sensitivity Specificity PPV NPV FFR CT 0.80 83.8 64.9 88.5 60.5 90.0 CCTA 43.1 85.2 31.2 25.2 88.9 100 80 83.8 85.2 88.5 90.0 88.9 60 43.1 64.9 60.5 40 20 31.2 25.2 0 Accuracy Sensitivity Specificity PPV NPV Leipsic et al. RSNA 2011

30-70% QCA Confirmed Stenosis FFR CT True Positive False Positive True Negative False Negative FFR CT 0.80 8 2 33 3 CCTA 10 25 10 1 40 33 25 20 0 8 10 10 2 3 1 True Positive False Positive True Negative FalseNegative

The DeFACTO Trial (Determination of Fractional Flow Reserve by Anatomic Computed Tomographic AngiOgraphy) 17-center international study of 252 patients undergoing CCTA and invasive FFR to evaluate the diagnostic performance of FFR CT Per-patient endpoint Enrollment complete LBCT ESC 2012 FFR 0.85 >50% diameter stenosis FFR CT 0.85 no ischemia >50% diameter stenosis FFR 0.84 no ischemia Source: http://clinicaltrials.gov/ct2/show/nct01233518?term=defacto&rank=1

JAMA. 2012;308(12):doi:10.1001/2012.jama.11274

Per-patient Diagnostic Performance of FFR CT 0.80 and CT 50% vs. FFR 0.80 For the Intention to Diagnose Sample FFR CT <0.80 CT >50% Estimate %, (95% CI) Subjects in group Estimate %, (95% CI) Subjects in group Sensitivity 90 (84-95) 129 84 (77-90) 129 Specificity 54 (46-83) 123 42 (34-51) 123 PPV 67 (60-74) 172 61 (53-67) 180 NPV 84 (74-90) 80 72 (61-81) 72 Accuracy 73 (67-78) 252 64 (58-70) 252

Areas under the receiver operator operating characteristics curve on a (A) per-patient and (B) per-vessel level for ischemia by FFR CT 0.80 and CT stenosis 50% as compared to invasive FFR

Conclusions FFR CT 1. Demonstrates high diagnostic performance compared to invasive measured FFR with 6 fold reduction in false positives for intermediate lesiosn as compared to CCTA when adequate image quality is achieved 2. >40% improvement in diagnostic accuracy compared to CCTA 3. Robust discrimination of ischemia-causing lesions FFR CT is a new computational method that may be considered for the physiologic assessment of intermediate stenoses identified by CCTA Careful adherence to best practice to ensure optimal image quality is highly valuable to ensure the most accurate results